NCT00814892View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

March 31, 2010

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

allogeneic tumor cell vaccine

Given intradermally

BIOLOGICAL

therapeutic autologous dendritic cells

Given intradermally

Trial Locations (1)

55905

Mayo Clinic Cancer Center, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT00814892 - Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter